Safety and Pharmacokinetics of Sialic Acid Tables in Patients With Hereditary Inclusion Body Myopathy (HIBM)
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-05-24
- Last Posted Date
- 2012-05-21
- Lead Sponsor
- Ultragenyx Pharmaceutical Inc
- Target Recruit Count
- 26
- Registration Number
- NCT01359319
- Locations
- 🇺🇸
Clinilabs, New York City, New York, United States
🇺🇸West Coast Clinical Trials, Costa Mesa, California, United States
© Copyright 2024. All Rights Reserved by MedPath